nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
A new tool to assess Clinical Diversity In Meta‐analyses (CDIM) of interventions
|
Barbateskovic, Marija |
|
|
135 |
C |
p. 29-41 |
artikel |
2 |
A proposed framework to guide evidence synthesis practice for meta-analysis with zero-events studies
|
Xu, Chang |
|
|
135 |
C |
p. 70-78 |
artikel |
3 |
Author queries via email text elicited high response and took less reviewer time than data forms – a randomised study within a review
|
Goossen, Käthe |
|
|
135 |
C |
p. 1-9 |
artikel |
4 |
Challenges in applying the GRADE approach in public health guidelines and systematic reviews: a concept article from the GRADE Public Health Group
|
Hilton Boon, Michele |
|
|
135 |
C |
p. 42-53 |
artikel |
5 |
Covariates adjustment questioned conclusions of predictive analyses: an illustration with the Kidney Donor Risk Index
|
Dantan, Etienne |
|
|
135 |
C |
p. 103-114 |
artikel |
6 |
Do not make clinical decisions based on abstracts of healthcare research: A systematic review
|
Nascimento, Dafne P. |
|
|
135 |
C |
p. 136-157 |
artikel |
7 |
Editorial Board
|
|
|
|
135 |
C |
p. IFC |
artikel |
8 |
Existing validated clinical prediction rules for predicting response to physiotherapy interventions for musculoskeletal conditions have limited clinical value: A systematic review
|
Walsh, Mary E. |
|
|
135 |
C |
p. 90-102 |
artikel |
9 |
External validation of clinical prediction models: simulation-based sample size calculations were more reliable than rules-of-thumb
|
Snell, Kym I.E. |
|
|
135 |
C |
p. 79-89 |
artikel |
10 |
Getting trustworthy guidelines into the hands of decision-makers and supporting their consideration of contextual factors for implementation globally: recommendation mapping of COVID-19 guidelines
|
Lotfi, Tamara |
|
|
135 |
C |
p. 182-186 |
artikel |
11 |
Improving the utility of evidence synthesis for decision makers in the face of insufficient evidence
|
Murad, M. Hassan |
|
|
135 |
C |
p. 170-175 |
artikel |
12 |
Measuring the success of blinding in placebo-controlled trials: Should we be so quick to dismiss it?
|
Webster, Rebecca K. |
|
|
135 |
C |
p. 176-181 |
artikel |
13 |
Metabolomics data complemented drug use information in epidemiological databases: pilot study of potential kidney donors
|
Klont, Frank |
|
|
135 |
C |
p. 10-16 |
artikel |
14 |
Reporting and methodological quality of COVID-19 systematic reviews needs to be improved: an evidence mapping
|
Li, Yanfei |
|
|
135 |
C |
p. 17-28 |
artikel |
15 |
Self-reported medication use among coronary heart disease patients showed high validity compared with dispensing data
|
Pedersen, Elisabeth |
|
|
135 |
C |
p. 115-124 |
artikel |
16 |
Should We Formalise the Assessment of Clinical Heterogeneity /Diversity In Systematic Reviews
|
Tugwell, Peter |
|
|
135 |
C |
p. A4-A5 |
artikel |
17 |
Table of Contents
|
|
|
|
135 |
C |
p. A2-A3 |
artikel |
18 |
The methodological quality is insufficient in clinical practice guidelines in the context of COVID-19: systematic review
|
Stamm, Tanja A. |
|
|
135 |
C |
p. 125-135 |
artikel |
19 |
The PROMISⓇ-Plus-Osteoarthritis of the Knee (OAK) profile measure integrates generic and condition-specific content to enhance relevance and efficiency
|
Yount, Susan E. |
|
|
135 |
C |
p. 158-169 |
artikel |
20 |
Use of GRADE in evidence syntheses published in high-impact-factor nutrition journals: A methodological survey
|
Werner, Sarah S |
|
|
135 |
C |
p. 54-69 |
artikel |